Welcome to Geneva Life Sciences

Save the date – Genève sciences de la vie

Mercredi 6 novembre 2019 – 17h00
FER Genève – 98, rue de Saint Jean – 1201 Genève

L’association Genève Sciences de la Vie a le plaisir de vous convier à fêter ses 70 ans pour une soirée de réflexion sur le passé, le présent et le futur des sciences de la vie.

Avec la participation de:
Pierre Maudet, Conseiller d’État.
Luc Ferry, écrivain et philosophe.
Geneviève Berger, médecin et biophysicienne,
Directrice du département R&D du groupe Firmenich.

Table ronde animée par Benoît Dubuis.

June 14, 2019

Menu

Switch Language

Social Link

Who we are

Our members

Our board

Employment

News

Contact

Newsletter

News

Save the date – Genève sciences de la vie

The dogtor is in: Study finds dogs can sniff out COVID-19 with 96% accuracy

GSK vaccine R&D chief jumps ship to Viome amid COVID-19 vaccine setbacks

Lonza va engager 1200 personnes dans son site de Viège

La pharma suisse loin derrière en matière d’innovation

[Health Valley] Ferring Biologics Innovation Centre opens at Biopôle

Swiss medical device startup CeQur scores $115M

Les 1000 idées de Solar Impulse pour le climat

The biggest tech trends of 2021, according to 3 founders

TOP 100 swiss Startups that equip the labs of tomorrow

Le CHUV : 9e meilleur hôpital du monde

Une piste genevoise pour la prise en charge du COVID?

Tessin: Lavazza et Barilla rejoignent un pôle de R&D à Lugano

Robotics developer Vicarious Surgical nets BD backing in $1.1B SPAC deal

Omada Health adds AI-powered physical therapy platform and a virtual clinic for diabetes, hypertension

Merck cans one COVID-19 drug, scraps a clinical trial of another

Scientists make long-lasting but controversial human-monkey embryos for medical research

GSK stops Keytruda combo trials after ICOS drug falls short

UPDATED: Thermo Fisher reels in PPD for $17.4B as it looks to follow the LabCorp playbook

Tectonic Therapeutic banks $80M to shift GPCR drug discovery toward biologics

Qlaris, armed with $25M round, pushes new glaucoma drug into clinic

Medtronic launches 7-day diabetes infusion tubing set in Europe

New name, new board, new focus: AltruBio relaunches with $63M series A

Bhargava leaves Gilead to take up post at biotech investor MPM

Tango finds a quick step to Wall Street via $353M SPAC deal

BioAge picks up muscle-aging program from Amgen, bringing pipeline count to 3

GeNeuro's experimental multiple sclerosis drug shows hints it may help treat COVID-19

Senti Biosciences in $645M Spark pact to drive gene circuits into the fast lane

Benchling logs largest funding round yet with $200M to expand cloud-based R&D platform

Bluebird, PsiOxus show oncolytic virus boosts CAR-T in solid tumors

Caption Health taps new CEO as it eyes expansion of its AI ultrasound tech

AstraZeneca, Sanguina to develop app for bloodless blood testing

Theseus Pharmaceuticals emerges from stealth with $100M series B and Ariad veterans at the helm

New approaches to AI, cell biology may have uncovered a novel drug target for COVID-19: Humans themselves

Moderna advancing early stage mRNA prospects to show depth beyond COVID-19 shot

Roche, Biocorp begin French rollout of add-on device connecting insulin pens to smartphone apps

Geneva Life Sciences